Metraipolis › archive › dc_42acfdf318bf

Nucleic Acid Therapeutics in Rare Disease: From Precision Medicine to Programmable Platforms — Europe PMC PMID:42972926

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42972926
DOI
10.1002/jimd.70262
License (as archived)
solo-consultazione
Archived
2026-11-08T01:00:52.776Z
SHA-256 of the archived text
c60a17510d43cc49c2334af9826cee458b3669191b90d0821c3838abc9f918a3
Stable URL of this page
https://metraipolis.com/documento/dc_42acfdf318bf

How to cite

Nucleic Acid Therapeutics in Rare Disease: From Precision Medicine to Programmable Platforms — Europe PMC PMID:42972926 — Europe PMC (en), https://europepmc.org/article/MED/42972926 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_42acfdf318bf (Metraipolis archive dc_42acfdf318bf, sha256 c60a17510d43cc49c2334af9826cee458b3669191b90d0821c3838abc9f918a3)
BibTeX
@misc{dc42acfdf318bf,
  title = {Nucleic Acid Therapeutics in Rare Disease: From Precision Medicine to Programmable Platforms — Europe PMC PMID:42972926},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42972926},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_42acfdf318bf; sha256 c60a17510d43cc49c2334af9826cee458b3669191b90d0821c3838abc9f918a3},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42972926. Agents can read the archived copy with the MCP tool read_document.